Jesse Taylor accepts 1-year USADA suspension

October 14, 2017

USADA announced that UFC welterweight Jesse Taylor has accepted a 1-year suspension for his use of Clomiphene.  The TUF Champion will not be able to return to the Octagon until September 2018.

Via USADA news release:

Taylor, 34, tested positive for clomiphene following an out-of-competition urine test conducted on August 22, 2017. Clomiphene is a Specified Substance in the class of Hormone and Metabolic Modulators and is prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency Prohibited List.

Clomiphene is not approved by the U.S. Food & Drug Administration (FDA) for use in the male population, as its use has not been thoroughly studied for safety and efficacy. Clomiphene also indirectly promotes the secretion of testosterone. Increasing testosterone, especially when combined with strength training, has been demonstrated to increase fat-free mass, muscle size, and strength in males, potentially leading to performance enhancement in sport.

Taylor’s one-year period of ineligibility, the highest sanction for a first offense involving a Specified Substance, began on September 13, 2017, the date his provisional suspension was imposed. As a result of his positive test, Taylor was removed from the Card for the UFC Fight Night event in Sydney, Australia, scheduled for November 18, 2017.

Payout Perspective:

Perhaps the only recourse for Taylor without expending a lot of legal costs.  Also, if he did not have a true excuse for his testing, it would only prolong the administrative battle.  It’s too bad for Taylor who just made it back into the organization.  The suspension also brings to light the issue of Clomiphene, a fertility drug for women, and the use of it by male competitors.

Got something to say?

You must be logged in to post a comment.